Prerna Mewawalla
Al-Ola A Abdallah and Prerna Mewawalla

Al-Ola A Abdallah: Dr. Mewawalla’s Presentation on Advances in CAR-T Therapies for Myeloma at ICET Congress

Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on X:

“Now on stage: Dr. Mewawalla presenting Advances in CAR-T Therapies in Myeloma — pushing the boundaries of innovation in patient care!”

Prerna Mewawalla, Myeloma and Transplant Physician, Associate Professor at Drexel University, shared a post by IPO, adding։

“Great to contribute at ICET Congress with a presentation on Advances in CAR-T Therapies for Myeloma. Continued innovation in this field is shaping earlier integration, enhancing durability, and improving patient outcomes. Looking forward to next-generation constructs including anito-cel, arlo-cel, NK-CARs, and dual-targeted approaches.”

Al-Ola A Abdallah

More from Al-Ola A Abdallah on OncoDaily.